These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 18082974)
1. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Fantegrossi WE; Ciullo JR; Wakabayashi KT; De La Garza R; Traynor JR; Woods JH Neuroscience; 2008 Jan; 151(2):533-43. PubMed ID: 18082974 [TBL] [Abstract][Full Text] [Related]
2. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472 [TBL] [Abstract][Full Text] [Related]
3. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors. Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935 [TBL] [Abstract][Full Text] [Related]
4. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698 [TBL] [Abstract][Full Text] [Related]
7. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. Johnson BN; Yamamoto BK J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423 [TBL] [Abstract][Full Text] [Related]
8. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Itzhak Y; Ali SF; Achat CN; Anderson KL Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354 [TBL] [Abstract][Full Text] [Related]
9. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Shankaran M; Gudelsky GA Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870 [TBL] [Abstract][Full Text] [Related]
10. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898 [TBL] [Abstract][Full Text] [Related]
11. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Crean RD; Davis SA; Von Huben SN; Lay CC; Katner SN; Taffe MA Neuroscience; 2006 Oct; 142(2):515-25. PubMed ID: 16876329 [TBL] [Abstract][Full Text] [Related]
12. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743 [TBL] [Abstract][Full Text] [Related]
13. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications. Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077 [TBL] [Abstract][Full Text] [Related]
14. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680 [TBL] [Abstract][Full Text] [Related]
15. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Clemens KJ; Cornish JL; Hunt GE; McGregor IS Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865 [TBL] [Abstract][Full Text] [Related]
16. Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques. Crean RD; Davis SA; Taffe MA Pharmacol Biochem Behav; 2007 May; 87(1):11-9. PubMed ID: 17475314 [TBL] [Abstract][Full Text] [Related]
17. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. Koprich JB; Campbell NG; Lipton JW Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762 [TBL] [Abstract][Full Text] [Related]
18. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
19. The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain. Putzke J; Spina MG; Büchler J; Kovar KA; Wolf G; Smalla KH Addict Biol; 2007 Mar; 12(1):69-80. PubMed ID: 17407499 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia. Jaehne EJ; Salem A; Irvine RJ Psychopharmacology (Berl); 2007 Sep; 194(1):41-52. PubMed ID: 17530474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]